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Items for this week’s Epi Update include: 
• FDA approves first vaccine for dengue 
• May 5 is World Hand Hygiene Day 
• Lyme disease testing recommendations 
• In the news: Cruise ship in St. Lucia quarantined over confirmed measles case 
• In the news: “Vampire facial” may have exposed spa clients to HIV, New Mexico 
health officials say 
• Infographic: Clean hands count 
• Meeting announcements and training opportunities 
 
FDA approves first vaccine for dengue 
The FDA has just approved the first vaccine for prevention of dengue disease. The vaccine is 
called Dengvaxia and is produced by Sanofi Pasteur. It is a live, attenuated vaccine that will 
cover all serotypes (1, 2, 3, and 4). It is a three dose series at 0, 6, and 12 months and is for 
persons 9 through 16 years of age who live in an endemic area and have previously had 
laboratory-confirmed dengue infection. 
  
Dengue is the most common mosquito-borne viral disease in the world and is endemic in the 
U.S. territories of American Samoa, Guam, Puerto Rico and U.S. Virgin Islands. An initial 
dengue infection is typically mild and may not cause any symptoms at all. However, 
subsequent infections can be quite serious and may lead to dengue hemorrhagic fever (DHF) 
which can be fatal. There are currently no specific treatments for dengue, other than 
supportive care. Three randomized, placebo-controlled studies on Dengvaxia involving 
approximately 35,000 people in endemic areas demonstrated a 76% effectiveness for 
preventing symptomatic, laboratory-confirmed dengue in persons aged 9 through 16 years 
who previously had laboratory-confirmed dengue. Reported side-effects included muscle and 
joint pain, fatigue, pain at the injection site and low-grade fever. It is hoped that the new 
vaccine will help provide protection to the estimated one third of the world’s population that 
lives in an at-risk area for dengue infection. 
  
For more information visit www.fda.gov/news-events/press-announcements/first-fda-approved-
vaccine-prevention-dengue-disease-endemic-regions. 
 
May 5 is World Hand Hygiene Day 
Hand-washing is one of the most important ways to prevent the spread of germs that make 
people sick. This Sunday, May 5 is World Hand Hygiene Day and a good time to remember 
the appropriate way to keep hands clean. Hands should be washed for 20 seconds with soap 
under clean, running water. Hand sanitizer can be used when soap and water are not available 
but it is not as effective at removing some germs like norovirus or when hands are visibly 
soiled. Hands should be cleaned during the following key times: 
• Before, during, and after preparing food 
• Before eating food 
• Before and after caring for someone at home who is sick with vomiting or diarrhea 
• Before and after treating a cut or wound 
• After using the toilet 
• After changing diapers or cleaning up a child who has used the toilet 
• After blowing your nose, coughing, or sneezing 
• After touching an animal, animal feed, or animal waste 
• After handling pet food or pet treats 
• After touching garbage 
For more information, visit www.cdc.gov/features/handwashing/index.html. 
 
Lyme disease testing recommendations 
CDC currently recommends a two-step process when testing blood for evidence of antibodies 
against the Lyme disease bacteria, Borrelia burgdorferi (utilizing the same blood sample). 
• The first step is a test called an enzyme immunoassay (EIA) or an indirect 
immunofluorescence assay (IFA). If negative, no further testing of the specimen is 
recommended. If positive or equivocal, additional testing should be performed. The 
additional testing step is necessary as the EIA tests are designed to be very 
sensitive, and may be positive for individuals who do not have Lyme disease. 
• The second step is a test called an immunoblot test, commonly, a Western blot test. 
Immunoblot tests for Lyme disease can detect two different classes of antibodies: 
IgM and IgG. IgM antibodies appear earlier, so testing for them can be helpful for 
identifying patients during the first few weeks of infection. However, IgM testing is 
more likely to give false positive results. Testing for IgG antibodies is more reliable, 
but can take up to 4-6 weeks to be detectable via immunoblot testing. 
The two steps of Lyme disease testing are designed to be done in tandem. CDC does not 
recommend performing one test without the other. Doing so will increase the frequency of false 
positive results and may lead to misdiagnosis. 
For more information on CDC’s testing recommendations and to download a figure showing 
CDC’s two-tiered testing decision tree, 
visit: www.cdc.gov/lyme/diagnosistesting/labtest/twostep/index.html. 
 
In the news: Cruise ship in St. Lucia quarantined over confirmed measles case 
www.nbcnews.com/news/us-news/cruise-ship-st-lucia-quarantined-over-confirmed-measles-
case-n1000751  
 
In the news: “Vampire facial” may have exposed spa clients to HIV, New Mexico health 
officials say  
www.abc15.com/news/national/-vampire-facial-may-have-exposed-spa-clients-to-hiv-new-
mexico-health-officials-say  
 
 
 
 
 
 
 
 
 
Infographic: Clean hands count 
 
To view in full size, visit www.cdc.gov/handhygiene/pdfs/Provider-Poster-Clean-Hands-Count-
508.pdf.     
 
Meeting announcements and training opportunities 
None 
 
Have a healthy and happy week! 
Center for Acute Disease Epidemiology 
Iowa Department of Public Health 
800-362-2736 
